In Britain, whether cannabis is treated as medicine or a crime may depend less on medical need than on the ability to pay. In 2018, the UK government changed drug policy, allowing specialist doctors to prescribe cannabis-based medicinal products.
The decision was presented as a move towards evidence-based healthcare, recognising cannabis may have therapeutic value for health conditions such as chemotherapy-induced nausea and vomiting, spasticity in adults with multiple sclerosis and treatment-resistant epilepsy. Nearly seven years later, though, access remains highly restricted. According to NHS guidance, medical cannabis is tightly controlled and usually considered only when other treatments have failed.
